Disease-specific human embryonic stem cell lines from King's College London placed on NIH Registry

Stem cell lines considered to be ideal research tools for designing models to understand disease progression

2013-09-24

(Press-News.org) Scientists from King's College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. The stem cell lines, which carry genes for a variety of hereditary disorders such as Huntington's disease, spinal muscular dystrophy and cystic fibrosis, are considered to be ideal research tools for designing models to understand disease progression, and ultimately in helping scientists develop new treatments for patients.

King's is now one of the five biggest providers of disease-specific human embryonic stem cells lines on the NIH Registry, and the largest from the UK. The development is a significant milestone for King's and keeps the university at the forefront of global research into regenerative medicine.

Embryonic stem cell lines are grown from frozen embryos donated by patients undergoing preimplantation genetic diagnosis (PGD) in conjunction with IVF treatment. Unlike 'adult' stem cells, embryonic stem cells can differentiate into any type of cell within the body and are considered to be more useful for stem cell-based therapies. Disease-specific stem cell lines are created from embryos found to be affected with genetic disorders and therefore not suitable for implantation, but offer huge potential for research into disease development.

King's has already developed eight clinical-grade and more than 30 research-grade stem cell lines, which were approved by the UK Stem Cell Steering Committee to be deposited with the UK Stem Cell Bank (UKSCB) and distributed worldwide.

The sixteen lines of stem cells on the NIH Registry carry genes for various hereditary disorders including Duchenne Muscular Dystrophy, Huntington's Disease, cystic fibrosis, and rarer conditions such as Von Hippel-Lindau Syndrome, Wiskott-Aldrich syndrome, spinal muscular atrophy, myotonic dystrophy and neurofibromatosis.

'Major contribution to global stem cell research'

Professor Peter Braude, Emeritus Professor of Obstetrics and Gynaecology, King's College London; and former director of the Stem Cell Programme and the Pre-Implantation Genetic Diagnosis Programme, Guy's and St Thomas' NHS Foundation Trust, said: 'We are delighted that the NIH has found our lines useful and their procurement and consents in line with the strict guidelines that they have set. This achievement is the culmination of over ten years of painstaking research and consistent belief in the scientific usefulness of these very special cells to improve our understanding of genetic disease processes.

'This is a huge milestone for King's, and will allow us to make a major contribution to global stem cell research by having these stem cell lines available to scientists in the USA.

'These research-grade stem cell lines are essential not only to address basic questions in development and disease, but to test and implement technical improvements in culture conditions that might affect hES cell viability and pluripotency.'

Dr Dusko Ilic, Senior Lecturer in Stem Cell Science at King's College London, said: 'I'm delighted that the NIH has accepted our stem cell lines. There are now significant opportunities for US-based researchers to use these lines as tools to test the molecular mechanisms of common diseases, so it's fantastic that they are now freely available to advance the science of stem cell therapy and regenerative medicine.'

INFORMATION:

CONTACT

Katherine Barnes
International PR Manager
King's College London
Tel: +44 207 848 3076
Email: katherine.barnes@kcl.ac.uk

About Reproductive Medicine at King's:

http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/index.aspx

Assisted Conception Unit, Guy's and St Thomas' NHS Foundation Trust:

http://www.guysandstthomasprivatehealthcare.co.uk/units/assisted-conception/

For further information about King's hES stem cells catalogue visit:

http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/hescell.aspx

For further information about the NIH Human Embryonic Stem Cell Registry visit:

http://grants.nih.gov/stem_cells/registry/current.htm?id=667

About King's College London King's College London is one of the top 20 universities in the world (2013/14 QS World University Rankings) and the fourth oldest in England. It is The Sunday Times 'Best University for Graduate Employment 2012/13'. A research-led university based in the heart of London, King's has more than 25,000 students (of whom more than 10,000 are graduate students) from nearly 140 countries, and more than 6,500 employees. King's is in the second phase of a £1 billion redevelopment programme which is transforming its estate.

King's has an outstanding reputation for providing world-class teaching and cutting-edge research. In the 2008 Research Assessment Exercise for British universities, 23 departments were ranked in the top quartile of British universities; over half of our academic staff work in departments that are in the top 10 per cent in the UK in their field and can thus be classed as world leading. The College is in the top seven UK universities for research earnings and has an overall annual income of nearly £554 million.

King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.

King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit: http://www.kingshealthpartners.org.

The College is in the midst of a five-year, £500 million fundraising campaign – World questions|King's answers – created to address some of the most pressing challenges facing humanity as quickly as feasible. The campaign's five priority areas are neuroscience and mental health, leadership and society, cancer, global power and children's health. More information about the campaign is available at http://www.kcl.ac.uk/kingsanswers.

ELSE PRESS RELEASES FROM THIS DATE:

Scientists discover environmental enrichment for TBI patients may counter shrinkage in the brain

2013-09-24

TORONTO, September 24, 2013 – For the first time, scientists at Toronto Rehab have found that in people with chronic moderate-severe traumatic brain injury (TBI), atrophy (shrinkage) in the brain may be countered by participating in environmental enrichment – increased physical, social and cognitive stimulation. The paper, entitled "Environmental enrichment may protect against hippocampal atrophy in the chronic stages of traumatic brain injury," was published today in the open-access journal Frontiers in Human Neuroscience. The principal investigator of this study is ...

World Heart Day 2013

2013-09-24

Sophia Antipolis, 29 September 2013: Obese children have blood vessel damage and insulin resistance that are precursors to atherosclerosis and diabetes, reveals research by Dr Norman Mangner presented at ESC Congress 2013. The findings highlight the need to adopt a healthy lifestyle early in life to prevent cardiovascular disease (CVD) which is the theme of World Heart Day 2013, held today. Professor Grethe Tell (Norway), ESC prevention spokesperson, said: "On World Heart Day 2013 the ESC is emphasising the importance of a healthy lifestyle from a young age. One in 10 ...

Professional French horn players in danger of developing noise-induced hearing loss

2013-09-24

FALLS CHURCH, Va. (September 24, 2013) — Professional French horn players may need to seriously consider adopting effective strategies to prevent noise induced hearing loss (NIHL). A new study published online in the Journal of Occupational and Environmental Hygiene (JOEH) found further evidence that French horn players are one of the most at-risk groups of developing NIHL among professional orchestral musicians. "Using both conservative and lenient criteria for hearing loss and correcting for age, we found that between 11 percent and 22 percent of the participants showed ...

Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients

2013-09-24

ATLANTA -- The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results were presented Monday at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO) conference. "Children are especially susceptible to the side effects of radiation therapy, and treating them for head and ...

Uphill for the trees of the world

2013-09-24

Human civilisation has had an impact on the world, and it continues to have an even greater impact. One of these is that the forests have been cleared and especially so in flat lowlands, so that they have gradually become restricted to steep terrain. This pattern is now emerging all across the world. Developed countries have been particularly efficient at removing forests from fertile, flat areas of land. The process has been going on throughout the last centuries, for example in Europe. And there is a clear correlation. The better the economy, the better the political ...

Penn Medicine researchers harness the immune system to fight pancreatic cancer

2013-09-24

PHILADELPHIA -- Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and frequently, its late stage at the time of diagnosis. A group of researchers led by the University of Pennsylvania's Perelman School of Medicine and Abramson Cancer Center, in collaboration with scientists from the University of Pittsburgh and University of Washington, published results of a clinical trial in which the standard chemotherapy ...

Past weight loss an overlooked factor in disordered eating

2013-09-24

PHILADELPHIA (September 24, 2013)— Dieters and weight loss researchers are familiar with the principle: The more weight you've lost, the harder it is to keep it off. A complex and vicious cycle of biological and behavioral factors make it so. But eating disorder research has largely overlooked this influence, and Dr. Michael Lowe, a professor of psychology at Drexel University, has published a flurry of research studies showing that needs to change. "The focus of eating disorder research has very much been on the state of patients' thoughts, beliefs, emotions and personalities," ...

Older is wiser, at least economically

2013-09-24

RIVERSIDE, Calif. — The brains of older people are slowing but experience more than makes up for the decline, a University of California, Riverside assistant professor of management and several colleagues found when asking the participants a series of financially related questions. Ye Li, the UC Riverside assistant professor, and Martine Baldassi, Eric J. Johnson and Elke U. Weber, all currently or formerly of Columbia University, outlined the results in a paper, "Complementary Cognitive Capabilities: Economic Decision Making, and Aging," which was just published in the ...

American College of Physicians releases new recommendations for treating obstructive sleep apnea

2013-09-24

PHILADELPHIA, September 24, 2013 -- People diagnosed with obstructive sleep apnea (OSA) should lose weight and use continuous positive airway pressure (CPAP) as initial therapy, according to new recommendations from the American College of Physicians (ACP) published today in Annals of Internal Medicine, ACP's flagship journal. More than 18 million American adults have sleep apnea, which increases the risk of high blood pressure, heart attack, stroke, heart failure, and diabetes and increases the chance of driving or other accidents. Sleep apnea is a leading cause of excessive ...

ACP issues recommendations for treating obstructive sleep apnea

2013-09-24

1. Guideline: ACP recommends weight loss and CPAP therapy for obstructive sleep apnea* *Sound bites and b-roll footage available. See bottom of page for feed dates, times, and coordinates People diagnosed with obstructive sleep apnea (OSA) should not consider surgery, according to new recommendations from the American College of Physicians (ACP). Instead, ACP recommends that patients lose weight and use continuous positive airway pressure (CPAP) as initial therapy. More than 18 million American adults have sleep apnea, which increases the risk of high blood pressure, ...

Disease-specific human embryonic stem cell lines from King's College London placed on NIH Registry

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: